Endoceutics Overview
- Year Founded
-
2006
- Status
-
Acquired/Merged
- Employees
-
95
- Latest Deal Type
-
Buyout/LBO
- Financing Rounds
-
3
- Investments
-
1
Endoceutics General Information
Description
Operator of a biopharmaceutical company intended for women's health and hormone-sensitive cancer prevention and treatment. The company specializes in developing hormone therapies for the treatment and prevention of breast cancer and endocrine-related disorders by advancing basic sciences, clinical research and product commercialization worldwide, thereby ensuring the benefits of effective, physiological and non-negative treatments for all menopausal problems to women.
Contact Information
Website
www.endoceutics.comCorporate Office
- 597 Sir Wilfrid Laurier Boulevard
- Mont-Saint-Hilaire, Quebec J3H 4X8
- Canada
Corporate Office
- 597 Sir Wilfrid Laurier Boulevard
- Mont-Saint-Hilaire, Quebec J3H 4X8
- Canada
Endoceutics Valuation & Funding
| Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
|---|
Endoceutics Comparisons
Industry
Financing
Details
Endoceutics Competitors (81)
One of Endoceutics’s 81 competitors is BioMarin Pharmaceutical, a Formerly PE-Backed company based in San Rafael, CA.
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| BioMarin Pharmaceutical | Formerly PE-Backed | San Rafael, CA | ||||
| Noven Pharmaceuticals | Corporate Backed or Acquired | Miami, FL | ||||
| Intas Pharmaceuticals | Private Equity-Backed | Ahmedabad, India | ||||
| Pfizer (Vienna) | Corporation | Vienna, Austria | ||||
| Mundipharma International | Private Equity-Backed | Cambridge, United Kingdom |
Endoceutics Signals
Endoceutics Acquisitions (1)
Endoceutics’s most recent deal was a Merger/Acquisition with Adare Pharmaceuticals (Pharmaceutical plant) for . The deal was made on 16-Jan-2017.
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Lead Partner |
|---|---|---|---|---|---|
| Adare Pharmaceuticals (Pharmaceutical plant) | 16-Jan-2017 | Merger/Acquisition | Buildings and Property |
Endoceutics FAQs
-
When was Endoceutics founded?
Endoceutics was founded in 2006.
-
Where is Endoceutics headquartered?
Endoceutics is headquartered in Mont-Saint-Hilaire, Canada.
-
What is the size of Endoceutics?
Endoceutics has 95 total employees.
-
What industry is Endoceutics in?
Endoceutics’s primary industry is Drug Discovery.
-
Is Endoceutics a private or public company?
Endoceutics is a Private company.
-
What is the current valuation of Endoceutics?
The current valuation of Endoceutics is .
-
What is Endoceutics’s current revenue?
The current revenue for Endoceutics is .
-
How much funding has Endoceutics raised over time?
Endoceutics has raised $85M.
-
Who are Endoceutics’s competitors?
BioMarin Pharmaceutical, Noven Pharmaceuticals, Intas Pharmaceuticals, Pfizer (Vienna), and Mundipharma International are some of the 81 competitors of Endoceutics.
-
When was Endoceutics acquired?
Endoceutics was acquired on 23-May-2023.
-
Who acquired Endoceutics?
Endoceutics was acquired by Cosette Pharmaceuticals.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process